Mark Elwood

Stocks Alert: Viavi Solutions Inc. (VIAV), Whole Foods Market, Inc. (WFM), GigPeak, Inc. (GIG)

Viavi Solutions Inc. (VIAV) grew with the stock adding 1.32% or $0.14 to close at $10.76 on active trading volume of 4.82M compared its three months average trading volume of 2.53M. The Milpitas California 95035 based company operating under the Communication Equipment industry has been trending up for the last 52 weeks, with the shares price now 76.1% up for the period and up by 31.54% so far this year. With price target of $9.46 and a 82.37% rebound from 52-week low, Viavi Solutions Inc. has plenty of upside potential, making it a hold with a view buy.

Viavi Solutions Inc. provides network test, monitoring, and assurance solutions to communications service providers, and enterprises and their ecosystems worldwide. The company operates through Network Enablement, Service Enablement, and Optical Security and Performance Products segments. The Network Enablement segment offers testing solutions that access the network to perform build-out and maintenance tasks. This segment provides solutions that include instruments, software and services to design, build, activate, certify, troubleshoot, and optimize networks. It also offers support and professional services, such as repair, calibration, software support, and technical assistance for the products; and system integration projects comprising project management, installation, and implementation, as well as product and technology training, and consulting services. The Service Enablement segment provides embedded systems and enterprise performance management solutions for communication service providers and enterprises with visibility into network, service, and application. This segment’s solutions include instruments, microprobes, and software, which monitor, collect, and analyze network data to reveal the actual customer experience and to identify opportunities for new revenue streams and network optimization. The Optical Security and Performance Products segment provides optical security solutions with a strategic focus on serving the anti-counterfeiting market through advanced security pigments, thread substrates, and printed features for the currency, pharmaceutical, and consumer electronic sectors. This segment also offers thin-film coating solutions for 3D sensing applications. The company was formerly known as JDS Uniphase Corporation and changed its name to Viavi Solutions Inc. in August 2015. Viavi Solutions Inc. was founded in 1979 and is headquartered in Milpitas, California.

Whole Foods Market, Inc. (WFM) gained $0.34 to close the day at a new closing price of $30.72, a 1.12% increase in value from its previous closing price that moved the stock 12.06% above its 52 week low of $27.67. A total of 4.75M shares exchanged hands during the day compared with its three month average trading volume of 4.84M. The stock, which fluctuated between $30.36 and $30.89 during the day, currently situated -12.47% below its 52 week high. The stock is down by -0.84% in the past one month and down by -3.65% over the past three months. With a one year target estimate of $29.6 and RSI of 54.22, the stock still has upside potential, making it a hold for now.

Whole Foods Market, Inc. operates natural and organic foods supermarkets. Its stores offers produce, packaged goods, bulk, frozen, dairy, meat, bakery, prepared foods, coffee, tea, beer, wine, cheese, nutritional supplements, vitamins, body care, pet foods, and household goods. As of November 2, 2016, the company operated 464 stores in the United States, Canada, and the United Kingdom. Whole Foods Market, Inc. was founded in 1978 and is headquartered in Austin, Texas.

GigPeak, Inc. (GIG) shares were up in last trading by 0.33% to $3.06. It experienced higher than average volume on day. The stock increased in value by almost 22.4% over the past week and grew 14.61% in the past month. It is currently trading 17.76% above its 50 day moving average and 28.89% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a 0% decrease in value from its one year high of $3.06. The RSI indicator value of 78.14, lead us to believe that it may reverse gains in the near term.

GigPeak, Inc. provides semiconductor ICs and software solutions for high-speed connectivity and video compression over the network and the cloud. The company designs, develops, and supplies analog, digital, and mixed signal components to enable high speed information streaming over the telecom networks, datacom infrastructure, and consumer electronics links. It offers a portfolio of modulator drivers and transimpedance amplifiers, and driver solutions to interface with the Lithium Niobate and Indium Phosphide optical modulators; optical, analog, and mixed signal solutions for high-speed data transmission products; wireless RF and MMIC products, including integrated broadband transceivers, transmitters, receivers, amplifiers, power detectors, and delay elements for microwave, millimeter- wave, and GNSS applications; and structured ASIC products to low geometry high end standard cells. The company’s industrial product line provides various digital and mixed-signal application specific integrated circuit solutions for industrial applications used in the military, avionics, medical, and communications markets. It markets and sells its products in Asia, North America, Europe, and internationally through direct sales force, distributors, and sales representatives. The company was formerly known as GigOptix, Inc. and changed its name to GigPeak, Inc. in April 2016. GigPeak, Inc. was founded in 2007 and is headquartered in San Jose, California.

 

Stocks Intraday Alert: Community Health Systems, Inc. (CYH), DDR Corp. (DDR), ZELTIQ Aesthetics, Inc. (ZLTQ)

Community Health Systems, Inc. (CYH) continued its upward trend with the stock climbing 7.4% or $0.49 to close the day at $7.11 on higher than average trading volume of 4.63M shares, compared to its three month average trading volume of 3.19M. The Franklin Tennessee 37067 based company has been outperforming the hospitals companies by 33.363% for last three months and its recent gains have pushed the stock slightly up 27.19% YTD, versus the hospitals industry which is up 4.04% for the same period. The RSI of 63.16 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Community Health Systems, Inc., together with its subsidiaries, owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. The company also provides outpatient services at urgent care centers, occupational medicine clinics, imaging centers, cancer centers, ambulatory surgery centers, and home health and hospice agencies. In addition, it offers management and consulting services to non-affiliated general acute care hospitals. As of February 15, 2016, the company owned, leased, or operated 195 affiliated hospitals in 29 states with approximately 30,000 licensed beds. Community Health Systems, Inc. was founded in 1985 and is headquartered in Franklin, Tennessee.

DDR Corp. (DDR) had a active trading with around 4.54M shares changing hands compared to its three month average trading volume of 2.85M. The stock traded between $14.43 and $14.73 before closing at the price of $14.53 with -2.09% change on the day. The Beachwood Ohio 44122 based company is currently trading -0.95% below its 52 week low of $14.43 and -27.06% below its 52 week high of $19.92. Both the RSI indicator and target price of 37.05 and $16.29 respectively, lead us to believe that it should be put on hold over the coming weeks.

DDR Corp. is an equity real estate investment trust. It invests in the real estate markets of the United States and Puerto Rico. The firm is in the business of acquiring, owning, developing, redeveloping, expanding, leasing and managing shopping centers. It formerly known as Developers Diversified Realty Corp. DDR Corp is based in Beachwood, Ohio.

ZELTIQ Aesthetics, Inc. (ZLTQ) traded within a range of $55.52 to $55.77 after opening the day at $55.59. The company has seen its stock increase in value by 27.69% so far this year. The stock was down close to -0.07% on active volume in last trading session and closed at $55.57 per share. After the recent fall, the stock is currently holding -1.09% below its 52 week high of $56.18 and 201.85% above its 12-month low of $20. The shares are up by over 40.22% in the last three months, and the RSI indicator value of 86.2 is bearish. The technical indicator is offering a warning sign that the stock can’t keep current pace going.

ZELTIQ Aesthetics, Inc., a medical technology company, engages in developing and commercializing non-invasive products for the selective reduction of fat. It offers CoolSculpting system, which utilizes proprietary controlled cooling technology to selectively reduce stubborn fat bulges. ZELTIQ Aesthetics, Inc. sells its products through a direct sales organization, as well as through a network of distributors to dermatologists, plastic surgeons, and aesthetic specialists primarily in North America, the Asia-Pacific, Europe, the Middle East, Africa, and Latin America. The company was formerly known as Juniper Medical, Inc. and changed its name to ZELTIQ Aesthetics, Inc. in July 2007. ZELTIQ Aesthetics, Inc. was founded in 2005 and is headquartered in Pleasanton, California.

 

3 Notable Runners: Calpine Corporation (CPN), INSYS Therapeutics, Inc. (INSY), SUPERVALU Inc. (SVU)

Calpine Corporation (CPN) managed to rebound with the stock climbing 2.9% or $0.33 to close the day at $11.69 on lower than average trading volume of 3.26M shares, compared to its three month average trading volume of 4.53M. The Houston Texas 77002 based company has been outperforming the electric utilities companies by 0.8789% for last three months and its recent gains have pushed the stock slightly up 2.27% YTD, versus the electric utilities industry which is up 1.43% for the same period. The RSI of 51.56 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Calpine Corporation, a wholesale power generation company, owns and operates natural gas-fired and geothermal power plants in North America. It operates natural gas-fired combustion turbines and renewable geothermal conventional steam turbines. The company sells power, steam, capacity, renewable energy credits, and ancillary services to utilities, independent electric system operators, industrial and agricultural companies, retail power providers, municipalities and other governmental entities, and power marketers, as well as retail commercial, industrial, and residential customers. As of February 1, 2017, it owned and operated 80 power plants, including 1 under construction with an aggregate generation capacity of 25,908 megawatts and 828 megawatts under construction. The company was founded in 1984 and is based in Houston, Texas.

INSYS Therapeutics, Inc. (INSY) had a light trading with around 3.24M shares changing hands compared to its three month average trading volume of 916.78K. The stock traded between $9.64 and $11 before closing at the price of $10.82 with 12.24% change on the day. The Lake Bluff 60044 based company is currently trading 24.37% above its 52 week low of $8.7 and -49.01% below its 52 week high of $21.22. Both the RSI indicator and target price of 64.1 and $18.2 respectively, lead us to believe that it should be put on hold over the coming weeks.

Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets Subsys, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant cancer patients in the United States. Its lead product candidate is Syndros, an orally administered liquid formulation of dronabinol. The company is also developing Cannabidiol Oral Solution, a synthetic cannabidiol for childhood catastrophic epilepsy syndromes; and other product candidates, including other dronabinol line extensions and sublingual spray product candidates. Insys Therapeutics, Inc. is headquartered in Chandler, Arizona.

SUPERVALU Inc. (SVU) traded within a range of $3.83 to $3.98 after opening the day at $3.87. The company has seen its stock decrease in value by -14.99% so far this year. The stock was up close to 2.85% on light volume in last trading session and closed at $3.97 per share. After the recent gain, the stock is currently holding -35.66% below its 52 week high of $6.17 and 9.07% above its 12-month low of $3.64. The shares are down by over -24.09% in the last three months, and the RSI indicator value of 44.49 is neither bullish nor bearish, tempting investors to stay on the sidelines.

SUPERVALU INC., together with its subsidiaries, operates as a grocery wholesaler and retailer in the United States. The company operates through three segments: Wholesale, Save-A-Lot, and Retail. The Wholesale segment offers wholesale distribution of various food and non-food products to independent retail customers, such as single and multiple grocery store independent operators, regional chains, and the military. This segment operates approximately 1,796 stores with a network spanning 40 states. The Save-A-Lot segment owns, operates, and licenses 1,360 discount grocery stores under the Save-A-Lot banner, including 897 licensed Save-A-Lot stores and 463 company-operated stores. The Retail segment operates retail stores that provide groceries and various additional products, including general merchandise, home, health and beauty care, and pharmacy products. This segment operates 200 stores under the Cub Foods, Shoppers Food & Pharmacy, Shop ’n Save, Farm Fresh, and Hornbacher’s banners, as well as 2 Rainbow and 2 County Market stores. The company provides a range of brand name and private-label products comprising perishable and nonperishable grocery products. SUPERVALU INC. was founded in 1871 and is headquartered in Eden Prairie, Minnesota.

 

3 Notable Runners: Regal Entertainment Group (RGC), Radian Group Inc. (RDN), CONSOL Energy Inc. (CNX)

Regal Entertainment Group (RGC) managed to rebound with the stock climbing 0.32% or $0.07 to close the day at $21.67 on higher than average trading volume of 2.77M shares, compared to its three month average trading volume of 1.9M. The Knoxville Tennessee 37918 based company has been underperforming the movie production, theaters companies by -4.9156% for last three months and its recent losses have trimmed gains to 5.19% YTD, versus the movie production, theaters industry which is up 3.09% for the same period. The RSI of 45.76 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Regal Entertainment Group, through its subsidiaries, operates as a motion picture exhibitor in the United States. It develops, acquires, and operates multi-screen theatres primarily in mid-sized metropolitan markets and suburban growth areas of larger metropolitan markets. The company operates a theatre circuit under the brands of Regal Cinemas, United Artists, Edwards, Great Escape Theatres, and Hollywood Theaters. As of January 6, 2017, it operated 7,310 screens in 565 theatres in 42 states along with Guam, Saipan, American Samoa, and the District of Columbia. Regal Entertainment Group was founded in 2002 and is based in Knoxville, Tennessee.

Radian Group Inc. (RDN) had a active trading with around 2.76M shares changing hands compared to its three month average trading volume of 2.53M. The stock traded between $19.41 and $19.68 before closing at the price of $19.57 with -0.2% change on the day. The Philadelphia Pennsylvania 19103 based company is currently trading 110.75% above its 52 week low of $9.29 and -1.51% below its 52 week high of $19.87. Both the RSI indicator and target price of 67.83 and $20.8 respectively, lead us to believe that it should be put on hold over the coming weeks.

Radian Group Inc., through its subsidiaries, provides mortgage and real estate products and services in the United States. It operates through two segments, Mortgage Insurance, and Mortgage and Real Estate Services (Services). The Mortgage Insurance segment provides credit-related insurance coverage, principally through private mortgage insurance that protects mortgage lenders from all or a portion of default-related losses on residential mortgage loans made to home buyers, as well as facilitates the sale of these mortgage loans in the secondary mortgage market. It offers primary mortgage insurance coverage on residential first-lien mortgage loans. This segment primarily serves mortgage bankers, mortgage brokers, commercial banks, savings institutions, credit unions, and community banks. The Services segment provides outsourced services, information-based analytics, and specialty consulting services for buyers and sellers of, and investors in, mortgage- and real estate-related loans and securities, and other asset-backed securities. This segment offers loan review and due diligence, monitoring of mortgage servicer and loan performance, valuation and component services, real estate owned asset management services, and outsourced mortgage services. Radian Group Inc. was founded in 1977 and is headquartered in Philadelphia, Pennsylvania.

CONSOL Energy Inc. (CNX) traded within a range of $16.94 to $17.31 after opening the day at $17.31. The company has seen its stock decrease in value by -6.36% so far this year. The stock was down close to -1.5% on light volume in last trading session and closed at $17.07 per share. After the recent fall, the stock is currently holding -23.59% below its 52 week high of $22.34 and 135.12% above its 12-month low of $7.14. The shares are down by over -7.38% in the last three months, and the RSI indicator value of 39.39 is neither bullish nor bearish, tempting investors to stay on the sidelines.

CONSOL Energy Inc., together with its subsidiaries, operates as an integrated energy company in the United States and internationally. The company primarily operates through two divisions, Exploration and Production (E&P), and Pennsylvania (PA) Mining Operations. The E&P division produces pipeline quality natural gas primarily to gas wholesalers. This division owns rights to extract natural gas in Pennsylvania, West Virginia, and Ohio from approximately 413,000 net Marcellus Shale acres; and 683,000 net acres of Utica Shale, as well as owns rights to extract coalbed methane (CBM) in Virginia from approximately 268,000 net CBM acres, which cover a portion of its coal reserves in Central Appalachia. It also owns rights to extract natural gas from shallow oil and gas positions in Illinois, Indiana, Kentucky, Pennsylvania, West Virginia, Virginia, and New York from approximately 766,000 net acres; 95,000 net acres of Chattanooga Shale; and 503,000 net acres of Huron Shale potential in Kentucky, West Virginia, and Virginia, as well as provides midstream gas services. The PA Mining Operations division engages in mining, preparation, and marketing of thermal coal primarily to power generators; and metallurgical coal. The company also provides energy services, including coal terminal services, water services, and land resource management services. CONSOL Energy Inc. was founded in 1864 and is headquartered in Canonsburg, Pennsylvania.

 

Momentum Stocks in Focus: Immunomedics, Inc. (IMMU), Uni-Pixel, Inc. (UNXL), SLM Corporation (SLM)

Immunomedics, Inc. (IMMU) continued its upward trend with the stock climbing 0.78% or $0.04 to close the day at $5.17 on light trading volume of 2.3M shares, compared to its three month average trading volume of 2.95M. The Morris Plains New Jersey 07950 based company has been outperforming the biotechnology group over the past 52 weeks, with the stock gaining 125.76%, compared to the industry which has advanced 0.95% over the same period. With RSI of 67.58, the stock should still continue to rise and get closer to its one year target estimate of $6, making it a hold for now.

Immunomedics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders, and other diseases. The company engages in developing antibody-drug conjugate (ADC) products comprising IMMU-132, an ADC that contains SN-38, which is in Phase II trials used for the treatment of patients with metastatic triple-negative breast cancer, and small-cell and non-small-cell lung cancers; IMMU-130, an anti-CEACAN5-SN-38 ADC that is in Phase II trials for the treatment of solid tumors and metastatic colorectal cancer; and epratuzumab, a humanized antibody that targets CD22, an antigen found on the surface of B lymphocytes. Its early-stage products include IMMU-114, a novel humanized antibody for the treatment of patients with B-cell and other cancers; Milatuzumab, a humanized monoclonal antibody targeting tumors that expresses the CD74 antigen, which is present on various hematological tumors and solid cancers; Veltuzumab, a humanized monoclonal antibody targeting CD20 receptors on B lymphocytes for the treatment of non-Hodgkin lymphoma and autoimmune diseases; and Yttrium-90-Labeled Epratuzumab Tetraxetan, a radiolabeled anti-CD22 investigational product. The company also provides LeukoScan, a diagnostic imaging product for diagnostic imaging to determine the location and extent of infection/inflammation in bone. In addition, it offers other product candidates for the treatment of solid tumors and hematologic malignancies, as well as other diseases, which are in various stages of clinical and pre-clinical development. The company has a research collaboration with The Bayer Group to study epratuzumab as a thorium-227-labeled antibody. Immunomedics, Inc. was founded in 1982 and is headquartered in Morris Plains, New Jersey.

Uni-Pixel, Inc. (UNXL) grew with the stock adding 5.83% or $0.06 to close at $1.09 on light trading volume of 2.3M compared its three months average trading volume of 440.78K. The Santa Clara California 95054 based company operating under the Diversified Electronics industry has been trending up for the last 52 weeks, with the shares price now 106.44% up for the period and up by 10.9% so far this year. With price target of $3.35 and a 202.78% rebound from 52-week low, Uni-Pixel, Inc. has plenty of upside potential, making it a hold with a view buy.

Uni-Pixel, Inc. designs, develops, manufactures, and markets micro-structured polymer film materials and related technologies for the display, flexible electronics, and automotive industries in the United States. The company markets its touch screen films under the brand XTouch, as sub-components of a touch sensor module; and hard coat resin and optical films under the Diamond Guard brand. Uni-Pixel, Inc. was founded in 1998 and is headquartered in Santa Clara, California.

SLM Corporation (SLM) continued its upward trend with the stock climbing 0.16% or $0.02 to close the day at $12.47 on lower than average trading volume of 2.29M shares, compared to its three month average trading volume of 3.8M. The Newark Delaware 19713 based company has been outperforming the credit services companies by 33.9985% for last three months and its recent gains have pushed the stock slightly up 13.16% YTD, versus the credit services industry which is up 7.05% for the same period. The RSI of 73.73 indicates the stock is overbought at the current levels, sell for now.

SLM Corporation, together with its subsidiaries, operates as a saving, planning, and paying for education company in the United States. It offers private education loans to students and their families. The company also provides banking products, such as certificates of deposits, money market deposit accounts, and high yield savings accounts; and a consumer savings network that offers financial rewards on everyday purchases to help families save for college. SLM Corporation was founded in 1972 and is headquartered in Newark, Delaware.

 

Momentum Stocks: Voya Financial, Inc. (VOYA), Allscripts Healthcare Solutions, Inc. (MDRX), Forum Energy Technologies, Inc. (FET)

Voya Financial, Inc. (VOYA) grew with the stock adding 2.1% or $0.88 to close at $42.88 on active trading volume of 1.84M compared its three months average trading volume of 1.68M. The New York New York 10169 based company operating under the Asset Management industry has been trending up for the last 52 weeks, with the shares price now 46.83% up for the period and up by 9.33% so far this year. With price target of $46.23 and a 88.6% rebound from 52-week low, Voya Financial, Inc. has plenty of upside potential, making it a hold with a view buy.

Voya Financial, Inc. operates as a retirement, investment, and insurance company in the United States. It operates through five segments: Retirement, Annuities, Investment Management, Individual Life, and Employee Benefits. The Retirement segment offers tax-deferred employer-sponsored retirement savings plans and administrative services in corporate, education, healthcare, and other non-profit and government entities; and rollover individual retirement accounts and other retail financial products, as well as financial advisory services to individual customers. This segment sells its products to small companies, corporations, and government entities directly, as well as through third-party administrators, wirehouse affiliated brokers, registered investment advisors, independent sales agents, and consulting firms. The Annuities segment provides fixed and indexed annuities, tax-qualified mutual fund custodial products, and other investment-only products and payout annuities for pre-retirement wealth accumulation and post-retirement income management through independent marketing organizations, independent and affiliated broker-dealers, banks, independent insurance agents, and pension professionals. The Investment Management segment offers fixed income, equity, multi-asset, and alternative products and solutions to individual and institutional customers directly, as well as through consultant channel, banks, broker-dealers, and independent financial advisers. The Individual Life segment provides wealth protection and transfer opportunities through universal, variable, and term life products. The Employee Benefits segment offers stop loss, group life, voluntary employee-paid, and disability products through brokers, consultants, third-party administrators, and private exchanges. The company was formerly known as ING U.S., Inc. and changed its name to Voya Financial, Inc. in April 2014. Voya Financial, Inc. was incorporated in 1999 and is based in New York, New York.

Allscripts Healthcare Solutions, Inc. (MDRX) had a light trading with around 1.82M shares changing hands compared to its three month average trading volume of 2.12M. The stock traded between $12.33 and $12.51 before closing at the price of $12.43 with -0.16% change on the day. The Chicago Illinois 60654 based company is currently trading 26.84% above its 52 week low of $9.8 and -18.06% below its 52 week high of $15.17. Both the RSI indicator and target price of  and $13.83 respectively, lead us to believe that it could rise over the coming weeks.

Allscripts Healthcare Solutions, Inc. provides information technology and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records, connectivity, hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. The company’s Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, hosting, revenue cycle management, training, and electronic claims administration services. Its Population Health segment offers health management and coordinated care solutions that enable hospitals, health systems, accountable care organizations, and other care facilities to connect, transition, analyze, and coordinate care across the entire care community. The company serves physicians, hospitals, governments, health systems, health plans, life-sciences companies, retail clinics, retail pharmacies, pharmacy benefit managers, insurance companies, and employer wellness clinics, as well as post-acute organizations, such as home health and hospice agencies. It has a strategic partnership with Nant Health, LLC. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Forum Energy Technologies, Inc. (FET) saw its value decrease by -2.12% as the stock dropped $-0.45 to finish the day at a closing price of $20.75. The stock was higher in trading and has fluctuated between $9.02-$26.25 per share for the past year. The shares, which traded within a range of $20.7 to $21.25 during the day, are up by 6.68% in the past three months and up by 16.44% over the past six months. It is currently trading -7.63% below its 20 day moving average and -8.78% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $23.44 a share over the next twelve months. The current relative strength index (RSI) reading is 37.53.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Forum Energy Technologies, Inc. designs, manufactures, and distributes products to the oil and natural gas industry in the United States and internationally. The company operates in two segments, Drilling & Subsea, and Production & Infrastructure. The Drilling & Subsea segment designs and manufactures products, and provides related services to the drilling, well and subsea construction, and completion and intervention markets. This segment also offers subsea technologies, including robotic vehicles and other capital equipment, specialty components and tooling, complementary subsea technical services and rental items, and applied products for subsea pipelines; drilling technologies consisting of capital equipment and a line of products consumed in the drilling and well intervention process; and down hole technologies comprising cementing and casing tools, completion products, and down hole protection solutions. The Production & Infrastructure segment designs and manufactures products, and provides related equipment and services to the well stimulation, production, and infrastructure markets. This segment supplies flow equipment, such as well stimulation consumable products, and related recertification and refurbishment services; production equipment, including well site production equipment and process equipment; and valve solutions comprising a range of industrial and process valves. In addition, the company designs, manufactures, and sells various completion and service tools, including retrievable and permanent packers, bridge plugs, and accessories to oilfield service providers, packer repair companies, and distributors. Forum Energy Technologies, Inc. is headquartered in Houston, Texas.

 

Stock’s Trend Analysis Report: Great Plains Energy Incorporated (GXP), Intellia Therapeutics Inc. (NTLA), comScore, Inc. (SCOR)

Great Plains Energy Incorporated (GXP) fell -1.03% during last trading as the stock lost $-0.29 to finish the day at $27.73 with about 1.5M shares changing hands, compared to its three month average trading volume of 2.65M. The $5.88B market cap company, which fluctuated between $27.59 and $27.94 during the day, currently situated 7.27% above its 52 week low of $25.85 and -12.87% away from its one year high of $32.74. The RSI of 55.96 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Great Plains Energy Incorporated, through its subsidiaries, generates, transmits, distributes, and sells electricity in Missouri and Kansas. It also provides regulated steam services in St. Joseph, Missouri. The company generates electricity using coal, nuclear, natural gas, oil, and wind resources. It has approximately 6,400 megawatts of generating capacity. The company sells electricity to 846,100 customers in the states of Missouri and Kansas, including 744,900 residences; 98,600 commercial firms; and 2,600 industrials, municipalities, and other electric utilities. Great Plains Energy Incorporated was founded in 1919 and is headquartered in Kansas City, Missouri.

Intellia Therapeutics Inc. (NTLA) dropped $-1.27 to close the day at a new closing price of $12.51, a -9.22% decrease in value from its previous closing price that moved the stock 5.44% above its 52 week low of $10.83. A total of 1.5M shares exchanged hands during the day compared with its three month average trading volume of 224.05K. The stock, which fluctuated between $10.83 and $14.27 during the day, currently situated -58.85% below its 52 week high. The stock is down by -4.65% in the past one month and down by -23.02% over the past three months. With a one year target estimate of $33.6 and RSI of 40.45, the stock still has upside potential, making it a hold for now.

Intellia Therapeutics Inc., a gene editing company, focuses on the development of therapeutics utilizing a biological tool known as the CRISPR/Cas9 system. The company develops in vivo programs focused on liver diseases, including transthyretin amyloidosis, alpha-1 antitrypsin deficiency, hepatitis B virus, and inborn errors of metabolism; and ex vivo applications of the technology in chimeric antigen receptor T cell and hematopoietic stem cell product candidates. It has a strategic collaboration and license agreement with Novartis focused on the development of new ex vivo CRISPR/Cas9-based therapies. Intellia Therapeutics Inc. was formerly known as AZRN, Inc. and changed its name to Intellia Therapeutics Inc. in July 2014. The company was founded in 2014 and is headquartered in Cambridge, Massachusetts.

comScore, Inc. (SCOR) had a active trading with around 1.5M shares changing hands compared to its three month average trading volume of 1.02M. The stock traded between $21.21 and $22.55 before closing at the price of $22.49 with 2.46% change on the day. The Reston Virginia 20190 based company is currently trading 8.07% above its 52 week low of $20.81 and -48.33% below its 52 week high of $43.53. Both the RSI indicator and target price of 22.39 and $30 respectively, lead us to believe that it could rise over the coming weeks.

comScore, Inc. operates as a cross-platform measurement company that measures audiences, brands, and consumer behavior worldwide. Its data footprint combines proprietary digital, TV, and movie intelligence with demographic details to quantify consumers’ multiscreen behavior. The company deliver custom solutions, syndicated reporting, cloud services (SaaS), and on-premise software to drive reporting, and real-time and predictive analytics. Its audience analytics products include MMX, an online audience measurement and media planning solution; Video Metrix that provides end-to-end video measurement in the online video marketplace; qSearch, which captures all of the search behavior at approximately 200 search properties in 38 individual countries and worldwide; Reach/Frequency suite that lays out campaign options and allows to analyze online advertising plans site-by-site and across media platforms; and Device Essentials to provide insight into unique digital device usage and traffic based on actual observed online visitation data. The company’s advertising analytics products comprise validated Campaign Essentials, a holistic ad and audience delivery validation solution; Action Lift to capture the effectiveness of a campaign; Brand Survey Lift to measure the overall branding impact of a campaign, as well as the specific lift contribution by publisher, data provider, and creative; validated Media Essentials to evaluate inventory by site, domain, section, and ad slot; and Brand Survey Lift Pulse to measure the breakthrough and impact of digital advertising in real-time. It serves agencies, CPG, education, energy, financial services, government, healthcare, investment research, manufacturing, media, pharmaceutical, professional services, retail, technology, telecommunications, and travel industries. comScore, Inc. has a strategic partnership with Adobe Systems Incorporated. The company was founded in 1999 and is headquartered in Reston, Virginia.

 

3 Stocks in Focus: TrueCar, Inc. (TRUE), Galectin Therapeutics, Inc. (GALT), Gentex Corporation (GNTX)

TrueCar, Inc. (TRUE) climbed 0.83% during last trading as the stock added $0.11 to finish the day at $13.34 with about 1.33M shares changing hands, compared to its three month average trading volume of 618.62K. The $1.12B market cap company, which fluctuated between $13.16 and $13.51 during the day, currently situated 201.95% above its 52 week low of $4.42 and -4.1% away from its one year high of $13.91. The RSI of 57.82 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

TrueCar, Inc., together with its subsidiaries, operates as an Internet-based information, technology, and communication services company. The company operates its platform on the TrueCar Website and TrueCar mobile applications. It also customizes and operates its platform for its affinity group marketing partners, including financial institutions, membership-based organizations, and employee buying programs for large enterprises. The company’s platform enables users to obtain market-based pricing data on new and used cars, and to connect with its network of TrueCar certified dealers. In addition, the company provides forecast, consulting, and other services regarding determination of the residual value of an automobile at future given points in time, which are used to underwrite automotive loans and leases, and by financial institutions to measure exposure and risk across loan, lease, and fleet portfolios. Further, TrueCar, Inc. offers geographically specific and real-time pricing information for consumers and dealers. The company was formerly known as Zag.com Inc. TrueCar, Inc. was founded in 2005 and is headquartered in Santa Monica, California.

Galectin Therapeutics, Inc. (GALT) dropped $-0.33 to close the day at a new closing price of $1.47, a -18.33% decrease in value from its previous closing price that moved the stock 200% above its 52 week low of $0.49. A total of 1.32M shares exchanged hands during the day compared with its three month average trading volume of 381.93K. The stock, which fluctuated between $1.4 and $1.78 during the day, currently situated -51.8% below its 52 week high. The stock is up by 41.35% in the past one month and up by 41.35% over the past three months. With a one year target estimate of $1.12 and RSI of 63.12, the stock still has upside potential, making it a hold for now.

Galectin Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic disease and cancer. The company’s lead product candidate includes galectin-3 inhibitor (GR-MD-02), a galactoarabino-rhamnogalacturonan polysaccharide polymer for the treatment of liver fibrosis and liver cirrhosis in non-alcoholic steatohepatitis patients, as well as for the treatment of cancer. It also engages in developing GM-CT-01, which is in pre-clinical development state for the treatment of cardiac and vascular fibrosis, as well as focuses on developing GR-MD-02 for the treatment of psoriasis. The company, through its collaborative joint venture, Galectin Sciences, LLC with SBH Sciences, Inc., is also involved in the research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics, Inc. was founded in 2000 and is based in Norcross, Georgia.

Gentex Corporation (GNTX) had a light trading with around 1.32M shares changing hands compared to its three month average trading volume of 2.2M. The stock traded between $20.41 and $20.6 before closing at the price of $20.51 with -0.44% change on the day. The Zeeland Michigan 49464 based company is currently trading 49.72% above its 52 week low of $13.99 and -6.3% below its 52 week high of $21.89. Both the RSI indicator and target price of 48.5 and $21.1 respectively, lead us to believe that it should be put on hold over the coming weeks.

Gentex Corporation designs, develops, manufactures, and markets automatic-dimming rearview mirrors and electronics for the automotive industry; dimmable aircraft windows for the aviation industry; and commercial smoke alarms and signaling devices for the fire protection industry worldwide. It offers automotive products, including interior and exterior electrochromic automatic-dimming rearview mirrors, automotive electronics, and interior and exterior non-automatic-dimming rearview mirrors with electronic features for automotive passenger cars, light trucks, pick-up trucks, sport utility vehicles, and vans for original equipment manufacturers, tier one automotive mirror manufacturers, and various aftermarket and accessory customers. The company also provides photoelectric smoke detectors and alarms, audible and visual signaling alarms, electrochemical carbon monoxide detectors and alarms, and bells and speakers for use in fire detection systems in office buildings, hotels, and other commercial and residential establishments. Gentex Corporation sells its fire protection products directly, as well as through sales managers and manufacturer representative organizations to fire protection and security product distributors, electrical wholesale houses, and original equipment manufacturers of fire protection systems. The company was founded in 1974 and is headquartered in Zeeland, Michigan.

 

Stocks To Track: Teladoc, Inc. (TDOC), New York REIT, Inc. (NYRT), Federated Investors, Inc. (FII)

Teladoc, Inc. (TDOC) fell -1.65% during last trading as the stock lost $-0.35 to finish the day at $20.9 with about 1.23M shares changing hands, compared to its three month average trading volume of 608.81K. The $1.08B market cap company, which fluctuated between $20.65 and $21.3 during the day, currently situated 130.18% above its 52 week low of $9.08 and -5.22% away from its one year high of $22.05. The RSI of 61.91 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Teladoc, Inc. provides telehealth services to its members and their customers in the United States. Its solution connects consumers with its physicians and behavioral health professionals that treat a range of conditions and cases, including acute diagnoses, such as upper respiratory infection, urinary tract infection, and sinusitis; dermatological conditions; anxiety; and smoking cessation. The company offers its services through mobile devices, the Internet, video, and phone. Teladoc, Inc. was founded in 2002 and is based in Purchase, New York.

New York REIT, Inc. (NYRT) gained $0.03 to close the day at a new closing price of $10, a 0.3% increase in value from its previous closing price that moved the stock 16.08% above its 52 week low of $8.79. A total of 1.23M shares exchanged hands during the day compared with its three month average trading volume of 2.93M. The stock, which fluctuated between $9.93 and $10 during the day, currently situated -7.49% below its 52 week high. The stock is up by 1.42% in the past one month and up by 3.73% over the past three months. With a one year target estimate of $11.13 and RSI of 57.12, the stock still has upside potential, making it a hold for now.

New York REIT, Inc. focuses on acquiring commercial real estate, as well as acquiring properties or making other real estate investments that relate to office, retail, multi-family residential, industrial, and hotel property types located primarily in New York City. It intends to qualify as a real estate investment trust for the U.S. federal income tax purposes. The company was formerly known as American Realty Capital New York Recovery REIT, Inc. New York REIT, Inc. was founded in October 2009 and is based in New York, New York.

Federated Investors, Inc. (FII) had a light trading with around 1.23M shares changing hands compared to its three month average trading volume of 895.87K. The stock traded between $26.26 and $27 before closing at the price of $27 with 1.81% change on the day. The Pittsburgh Pennsylvania 15222 based company is currently trading 20.09% above its 52 week low of $24.42 and -13.57% below its 52 week high of $33.13. Both the RSI indicator and target price of 56.68 and $26.33 respectively, lead us to believe that it should be put on hold over the coming weeks.

Federated Investors, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides its services to individuals, including high net worth individuals, banking or thrift institutions, investment companies, pension and profit sharing plans, pooled investment vehicles, charitable organizations, state or municipal government entities, and registered investment advisors. Through its subsidiaries, it manages separate client-focused equity, fixed income, balanced and money market mutual funds along with separate client-focused equity, fixed income, money market, and balanced portfolios. Through its subsidiaries, the firm invests in the public equity and fixed income markets across the globe. It invests in growth and value stocks of small-cap, mid-cap, and large-cap companies. The firm makes its fixed income investments in ultra-short, short-term, and intermediate-term mortgage-backed, U.S. Government, U.S. corporate, high yield, and municipal securities. It employs both fundamental and quantitative analysis to make its equity investments. Federated Investors, Inc. was founded in 1955 and is based in Pittsburgh, Pennsylvania with additional offices in New York City and London, United Kingdom.

 

Stocks on the Move: Cobalt International Energy, Inc. (CIE), Bellerophon Therapeutics, Inc. (BLPH), Sino-Global Shipping America, Ltd. (SINO)

Cobalt International Energy, Inc. (CIE) managed to rebound with the stock climbing 8.39% or $0.06 to close the day at $0.83 on light trading volume of 11.52M shares, compared to its three month average trading volume of 5.11M. The Houston Texas 77024 based company has been underperforming the independent oil & gas group over the past 52 weeks, with the stock losing -63.76%, compared to the industry which has advanced 52.17% over the same period. With RSI of 35.54, the stock should still continue to rise and get closer to its one year target estimate of $2.69, making it a hold for now.

Cobalt International Energy, Inc., through its subsidiaries, operates as an oil and gas exploration and production company primarily in the deepwater U.S. Gulf of Mexico. The company holds interests in the North Platte, Shenandoah, Anchor, and Heidelberg fields located in the U.S. Gulf of Mexico; and the Diaba block located offshore Gabon. As of December 31, 2015, it had net proved undeveloped reserves of 5.6 million barrels (MMBbls) of oil; 0.3 MMBbls of natural gas liquids; and 1.8 billion cubic feet of natural gas. The company was founded in 2005 and is based in Houston, Texas.

Bellerophon Therapeutics, Inc. (BLPH) climbed 37.84% during last trading as the stock added $0.28 to finish the day at $1.02 with about 8.18M shares changing hands, compared to its three month average trading volume of 694.39K. The $30.31M market cap company, which fluctuated between $0.74 and $1.14 during the day, currently situated 135.57% above its 52 week low of $0.43 and -77.73% away from its one year high of $4.58. The RSI of 80.38 indicates the stock is overbought at the current levels, sell for now.

Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products at the intersection of drugs and devices that address unmet medical needs in the treatment of cardiopulmonary diseases. Its product candidates include INOpulse, a pulsatile nitric oxide delivery device, which has completed Phase II clinical trials for the treatment of pulmonary arterial hypertension, as well as in Phase II clinical trials to treat pulmonary hypertension associated with chronic obstructive pulmonary diseases; and bioabsorbable cardiac matrix, a medical device for the prevention of congestive heart failure. Bellerophon Therapeutics, Inc. was founded in 2009 and is headquartered in Warren, New Jersey.

Sino-Global Shipping America, Ltd. (SINO) saw its value decrease by -6.17% as the stock dropped $-0.29 to finish the day at a closing price of $4.41. The stock was higher in trading and has fluctuated between $0.4-$14.2 per share for the past year. The shares, which traded within a range of $4.27 to $5.5 during the day, are up by 201.6% in the past three months and up by 139.67% over the past six months. It is currently trading 49.54% above its 20 day moving average and 37.77% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $0 a share over the next twelve months. The current relative strength index (RSI) reading is 70.3. The technical indicator do not lead us to believe the stock will see more gains any time soon.

Sino-Global Shipping America, Ltd. provides shipping agency and inland transportation management services in the United States, the People’s Republic of China, Australia, and Canada. Its shipping agency services include loading/discharging and protective services. The company was founded in 2001 and is headquartered in Roslyn, New York.